Additional studies are needed to determine whether patients with GBS with neurofascin IgM are at higher risk of progressing to CIDP or whether IgM antibodies contribute to pathogenesis. Here, NFASC is linked to chronic inflammatory demyelinating polyradiculoneuropathy.